Examination Report |
1 | Additional Representation Sheet | 23 Nov 2010 |
10 | Hearing Notice | 28 Aug 2017 |
11 | Journal Copy | 18 Jan 2018 |
12 | Certificate | 30 Jan 2018 |
13 | TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT) | 28 Feb 2018 |
14 | TM-R(RENEWAL OF TRADE MARK) | 12 Dec 2019 |
2 | TM-1 | 23 Nov 2010 |
3 | Correspondence | 23 Nov 2010 |
4 | Reply to Exam Report (MIS-R) | 06 Jun 2012 |
5 | Reply to Exam Report (MIS-R) | 26 Jun 2012 |
6 | Authorization Document (POA) | 07 Jan 2015 |
7 | TM-16 | 07 Jan 2015 |
8 | TM-16 | 20 May 2015 |
9 | Hearing Notice | 18 Feb 2016 |
1 | Hearing Notice (Show Cause) | 4911958 | 04 Jul 2017 | |
2 | Tribunal ABA Notice for : 2057415 | 5073570 | 30 Aug 2017 | |
3 | RENEWAL INTIMATION LETTER | 9616345 | 21 Jan 2020 |
The application for Letamol was made on 23 November 2010.
The trademark applicant for Letamol is SUN PHARMACEUTICAL INDUSTRIES.
Letamol is applied in class(es) 5.
Application for Letamol is on Registered stage.
Application Id allotted to Letamol is 2057415.
Letamol filed with the Intellectual property office as a WORD.